论文部分内容阅读
目的:探讨老年糖尿病患者的胰岛素治疗应用价值。方法:2013年7月到2015年8月选择在我院诊治的老年糖尿病患者70例,根据入院顺序分为观察组与对照组,各35例,对照组给予常规治疗,观察组在对照组治疗的基础上给予中效胰岛素治疗,两组都连续治疗4周。结果:治疗后两组的空腹血糖和餐后2h血糖值明显低于治疗前(P<0.05),同时治疗后观察组的空腹血糖及餐后2h血糖明显低于对照组(P<0.05)。治疗后观察组与对照组的糖化血红蛋白值均明显低于治疗前,且治疗后观察组的糖化血红蛋白值也明显低于对照组(P<0.05)。结论:老年糖尿病患者采用中效胰岛素辅助治疗能有效促进血糖的降低与糖化血红蛋白指标的改善,有很好的应用价值。
Objective: To investigate the value of insulin therapy in elderly diabetic patients. Methods: From July 2013 to August 2015, 70 elderly diabetic patients were selected for treatment in our hospital. According to the order of admission, the patients were divided into observation group and control group, 35 cases in each group. The control group was given routine treatment. The observation group was treated in control group On the basis of given to the treatment of insulin, both groups were treated for 4 weeks. Results: After treatment, fasting blood glucose and 2h postprandial blood glucose were significantly lower than those before treatment (P <0.05). After treatment, the fasting blood glucose and 2h postprandial blood glucose in the observation group were significantly lower than those in the control group (P <0.05). After treatment, the values of HbA1c in the observation group and the control group were significantly lower than those before treatment, and the values of HbA1c in the observation group were also significantly lower than those in the control group (P <0.05). Conclusion: The middle-effect insulin adjuvant therapy can effectively promote the decrease of blood glucose and the improvement of HbA1c in elderly patients with diabetes mellitus, which has a good application value.